SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000891092-08-000978
Filing Date
2008-02-14
Accepted
2008-02-14 09:03:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e30387sc13g.txt SC 13G 7787
  Complete submission text file 0000891092-08-000978.txt   9678
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83614 | Film No.: 08608653
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC 13G